Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

TPL-2 kinase regulates the proteolysis of the NF-κB-inhibitory protein NF-κB1 p105

Abstract

The transcription factor NF-κB is composed of homodimeric andheterodimeric complexes of Rel/NF-κB-family polypeptides, which include Rel-A, c-Rel, Rel-B, NF-κB1/p50 and NF-κB2/p52 (ref. 1). The NF-κB1 gene encodes a larger precursor protein, p105, from which p50 is produced constitutively by proteasome-mediated removal of the p105 carboxy terminus2,3,4,5. The p105 precursor also acts as an NFκB-inhibitory protein, retaining associated p50, c-Rel and Rel-A proteins in the cytoplasm through its carboxy terminus6,7. Following cell stimulation by agonists, p105 is proteolysed more rapidly and released Rel subunits translocate into the nucleus8,9,10. Here we show that TPL-2 (ref. 11), which ishomologous to MAP-kinase-kinase kinases in its catalytic domain12, forms a complex with the carboxy terminus of p105. TPL-2 was originally identified, in a carboxy-terminal-deleted form, as an oncoprotein in rats11 and is more than 90% identical to the human oncoprotein COT13. Expression of TPL-2 results in phosphorylation and increased degradation of p105 while maintaining p50production. This releases associated Rel subunits or p50–Rel heterodimers to generate active nuclear NF-κB. Furthermore, kinase-inactive TPL-2 blocks the degradation of p105 induced by tumour-necrosis factor-α. TPL-2 is therefore a component of a new signalling pathway that controls proteolysis of NF-κB1 p105.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: TPL-2 interacts with the C terminus of NF-κB1 p105 in vitro .
Figure 2: The TPL-2 C terminus is required for interaction with NF-κB1 p105 in vitro.
Figure 3: TPL-2 associates with p105 in vivo.
Figure 4: Co-expression of TPL-2 with Myc-p105 induces nuclear translocation of Myc-p50.
Figure 5: TPL-2 promotes nuclear translocation of p50 independently of p105 processing.
Figure 6: TPL-2 stimulates proteolysis of co-expressed Myc–p105 by the proteasome.
Figure 7: TPL-2 activity is required for TNFα-induced degradation of p105.

Similar content being viewed by others

References

  1. Ghosh, S., May, M. J. & Kopp, E. B. NF-κB and Rel proteins: evolutionary conserved mediators of immune responses. Annu. Rev. Immunol. 16, 225–260 (1998).

    Article  CAS  Google Scholar 

  2. Ghosh, S. et al. Cloning of the p50 DNA binding subunit of NF-κB: homology to rel and dorsal. Cell 62, 1019–1029 (1990).

    Article  CAS  Google Scholar 

  3. Kieran, M. et al. The DNA binding subunit of NF-κB is identical to factor KBF1 and homologous to the rel oncogene product. Cell 62, 1007–1018 (1990).

    Article  CAS  Google Scholar 

  4. Palombella, V. J., Rando, O. J., Goldberg, A. L. & Maniatis, T. The ubiquitin-proteasome pathway is required for processing the NF-κB 1 precursor protein and activation of NF-κB. Cell 78, 773–785 (1994).

    Article  CAS  Google Scholar 

  5. Lin, L., DeMartino, G. N. & Greene, W. C. Cotranslational biogenesis of NF-κB p50 by the 26S proteasome. Cell 92, 819– 828 (1998).

    Article  CAS  Google Scholar 

  6. Rice, N. R., MacKichan, M. L. & Israel, A. The precursor of NF-κB p50 has IκB-like functions. Cell 71, 243– 253 (1992).

    Article  CAS  Google Scholar 

  7. Mercurio, F., DiDonato, J. A., Rosette, C. & Karin, M. p105 and p98 precursor proteins play an active role in NF-κB-mediated signal transduction. Genes Dev. 7, 705– 718 (1993).

    Article  CAS  Google Scholar 

  8. Donald, R., Ballard, D. W. & Hawiger, J. Proteolytic processing of NF-κB/IκB in human monocytes. J.Biol. Chem. 270, 9– 12 (1995).

    Article  CAS  Google Scholar 

  9. MacKichan, M. L., Logeat, F. & Israel, A. Phosphorylation of p105 PEST sequences via a redox-insensitive pathway up-regulates processing to p50 NF-κB. J. Biol. Chem. 271, 6084–6091 ( 1996).

    Article  CAS  Google Scholar 

  10. Mellits, K. H., Hay, R. T. & Goodbourn, S. Proteolytic degradation of MAD3 (IκBα) and enhanced processing of the NF-κB precursor p105 are obligatory steps in the activation of NF-κB. Nucleic Acids Res. 21, 5059–5066 (1993).

    Article  CAS  Google Scholar 

  11. Patriotis, C., Makris, A., Bear, S. E. & Tsichlis, P. N. Tumor progression locus 2 (Tpl-2) encodes a protein kinase involved in the progression of rodent T cell lymphomas and in T cell activation. Proc. Natl Acad. Sci. USA 90, 2251–2255 (1993).

    Article  ADS  CAS  Google Scholar 

  12. Salmeron, A. et al. Activation of MEK-1 and SEK-1 by Tpl-2 proto-oncoprotein, a novel MAP kinase kinase kinase. EMBO J. 15, 817–826 (1996).

    Article  CAS  Google Scholar 

  13. Aoki, M. et al. The human cot proto-oncogene encodes two protein serine/threonine kinases with different transforming activities by alternative initiation of translation. J. Biol. Chem. 268, 22723– 22732 (1993).

    CAS  PubMed  Google Scholar 

  14. Fromont-Racine, M., Rain, J. -C. & Legrain, P. Toward a functional analysis of the yeast genome through exhaustive two-hybrid analysis. Nature Genet. 16, 277–282 (1997).

    Article  CAS  Google Scholar 

  15. Malinin, N. L., Boldin, M. P., Kovalenko, A. V. & Wallach, D. MAP 3K-related kinase involved in NF-κB induction by TNF, CD95 and IL-1. Nature 385, 540–544 (1997).

    Article  ADS  CAS  Google Scholar 

  16. May, M. J. & Ghosh, S. Signal transduction through NF-κB. Immunol. Today 19, 80– 88 (1998).

    Article  CAS  Google Scholar 

  17. Henkel, T. et al. Intramolecular masking of the nuclear location signal and dimerization domain in the precursor for the p50 NF-κB subunit. Cell 68, 1121–1133 ( 1992).

    Article  CAS  Google Scholar 

  18. Watanabe, N., Iwamura, T., Shinoda, T. & Fujita, T. Regulation of NF-κB1 proteins by the candidate oncoprotein BCL-3: generation of NF-κB homodimers from the cytoplasmic pool of p50-p105 and nuclear translocation. EMBO J. 16, 3609–3620 ( 1997).

    Article  CAS  Google Scholar 

  19. Blank, V., Kourilsky, P. & Israel, A. Cytoplasmic retention, DNA binding and processing of the NF-κB p50 precursor are controlled by a small region in its C-terminus. EMBO J. 10, 4159–4167 (1991).

    Article  CAS  Google Scholar 

  20. Lin, L. & Ghosh, S. Aglycine-rich region in NF-κB p105 functions as a processing signal for the generation of the p50 subunit. Mol. Cell. Biol. 16, 2248– 2254 (1996).

    Article  CAS  Google Scholar 

  21. Zandi, E., Rothwarf, D. M., Delhase, M., Hayakawa, M. & Karin, M. The IκB kinase complex (IKK) contains two kinase subunits, IKK-α and IKK-β, necessary for IκB phosphorylation and NF-κB activation. Cell 91 , 243–252 (1997).

    Article  CAS  Google Scholar 

  22. Mercurio, F. et al. IKK-1 and IKK-2: cytokine-activated IκB kinases essential for NF-κB activation. Science 278, 860–866 (1997).

    Article  ADS  CAS  Google Scholar 

  23. Woronicz, J. D., Gao, X., Cao, Z., Rothe, M. & Goeddel, D. V. IκB kinase-β: NF-κB activation and complex formation with IκB kinase-α and NIK. Science 278, 866–869 ( 1997).

    Article  ADS  CAS  Google Scholar 

  24. Ceci, J. D. et al. TPL-2 is an oncogenic kinase that is activated by carboxy-terminal truncation. Genes Dev. 11, 688– 700 (1997).

    Article  CAS  Google Scholar 

  25. Cowley, S., Paterson, H., Kemp, P. & Marshall, C. J. Activation of MAP kinase kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH 3T3 cells. Cell 77, 841–852 (1994).

    Article  CAS  Google Scholar 

  26. Fan, C. -M. & Maniatis, T. Generation of p50 subunit of NF-κB by processing of p105 through an ATP-dependent pathway. Nature 354, 395–398 ( 1991).

    Article  ADS  CAS  Google Scholar 

  27. Kabouridis, P. S., Magee, A. I. & Ley, S. C. S-acylation of LCK protein tyrosine kinase is essential for its signalling function in T lymphocytes. EMBO J. 16, 4983–4998 (1997).

    Article  CAS  Google Scholar 

  28. Huby, R. D. J., Iwashima, M., Weiss, A. & Ley, S. C. ZAP-70 protein tyrosine kinase is constitutively targeted to the T cell cortex independently of its SH2 domains. J. Cell. Biol. 137, 1639–1649 (1997).

    Article  CAS  Google Scholar 

  29. Alkalay, I. et al. In vivo stimulation of IκB phosphorylation is not sufficient to activate NF-κB. Mol. Cell. Biol. 15, 1294–1301 (1995).

    Article  CAS  Google Scholar 

  30. Lenardo, M. J. & Baltimore, D. NF-κB: a pleiotropic mediator of inducible and tissue-specific gene control. Cell 58, 227–229 ( 1989).

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank P. Legrain and the Pasteur Institute for help in setting up the yeast two-hybrid assay and for the liver cDNA library; A. Israel, T. Maniatis, P. Tsichlis, D. Wallach and N.Watanabe for reagents; H. Coope, J. Janzen and T. Johnson for technical assistance; and H.Allen and T. Magee for helpful discussions. This work was supported by the MRC.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Steven C. Ley.

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Cite this article

Belich, M., Salmerón, A., Johnston, L. et al. TPL-2 kinase regulates the proteolysis of the NF-κB-inhibitory protein NF-κB1 p105. Nature 397, 363–368 (1999). https://doi.org/10.1038/16946

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/16946

This article is cited by

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing